Dexcom CGM Hospital Use During the COVID-19 Pandemic

Information for Healthcare Providers:
Dexcom G6 CGM System in the Hospital

On April 1, 2020, the Federal Drug Administration (FDA) notified Dexcom that it is exercising its enforcement discretion and will not object to the use of continuous glucose monitoring (CGM) systems for the treatment of patients in hospital settings and other healthcare facilities to support COVID-19 healthcare-related efforts during the current pandemic. This does not expand Dexcom’s current authorized indications for use for its home use product.

Extending use of the Dexcom CGM systems to hospitalized patients during the COVID-19 emergency in order to allow hospital staff to remotely monitor glucose in patients may reduce provider/patient interaction, limiting viral exposure by hospital staff, and conserve personal protective equipment.

However, the Fact Sheet for Healthcare Providers should be reviewed carefully before using the Dexcom CGM systems in hospital settings.

Fact sheet for providers Get started in the hospital

FDA Grants Breakthrough Device Designation for Dexcom Hospital CGM System

Dexcom CGM for use in the hospital setting was granted FDA Breakthrough Device Designation. The Breakthrough Device program is designed to expedite the development and regulatory review of medical devices that hold the potential for more effective treatment of life-threatening or irreversibly debilitating disease or condition.

This does not expand Dexcom’s current authorized indications for use of its home use product.

View the Press Release

Dexcom G6 in the Hospital Setting

Watch and learn more about the value and use of CGM in the hospital.

Overview of Dexcom G6

Clinical Use of CGM

Clinical Evidence

Review evidence demonstrating the impact that CGM use can have on glucose management in hospital.

Complete this form to learn more about using Dexcom G6 in the hospital, including meeting with our team and ordering product for the hospital.

Hospital Name *

Hospital City *

Hospital State *

Hospital County *

Email *

Phone Number *

Contact Information *

How did you hear about using Dexcom G6 for hospitalized patients during the COVID-19 pandemic? *

Opt in

Click here to indicate your intent to participate in this registry and Dexcom will send you information on the registry once it has been launched.

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

What is CGM?

CGM vs. BGM

MM: Benefits of CGM

Benefits of CGM

Customer Stories

Become a Dexcom Warrior

Advocacy Organizations

Contact Us

Information for Healthcare Providers:
Dexcom G6 CGM System in the Hospital

FDA Grants Breakthrough Device Designation for Dexcom Hospital CGM System

Dexcom G6 in the Hospital Setting

Overview of Dexcom G6

Clinical Use of CGM

Clinical Evidence

Real-Time CGM in Intensive Care Units

Real-Time CGM in Non-Intensive Care Units

Resource

Information Request for Healthcare Providers

Information for Healthcare Providers:Dexcom G6 CGM System in the Hospital

FDA Grants Breakthrough Device Designation for Dexcom Hospital CGM System

Overview of Dexcom G6

Clinical Use of CGM

Clinical Evidence

Real-Time CGM in Intensive Care Units

Real-Time CGM in Non-Intensive Care Units

Resource

Information for Healthcare Providers:
Dexcom G6 CGM System in the Hospital